← Back to Search
Behavioral Intervention
NIMH Clinical Pathway for Suicide Prevention
Morgantown, WV
N/A
Recruiting
Led By Mary Christensen, PhD, LICSW
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Youth and Parent must be English-speaking
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up total period of 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a suicide risk screening program called the "NIMH Clinical Pathway" in two school-based health centers in West Virginia. The goal is to see if this program can effectively screen
See full description
Who is the study for?
This trial is for adolescents attending school-based health centers in West Virginia. It's focused on those who may be at risk of suicide and can benefit from routine screening and follow-up care. The study seeks input from providers, parents, and youth to tailor the program effectively.Check my eligibility
What is being tested?
The 'NIMH Clinical Pathway' is being tested for its ability to screen for suicide risk and provide appropriate follow-up actions like safety planning and referrals. This trial will adapt this evidence-based program specifically for rural Appalachian school settings.See study design
What are the potential side effects?
Since this intervention involves screening procedures rather than medications, traditional side effects are not applicable. However, there might be emotional or psychological impacts due to discussing sensitive topics such as suicide.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
Both my child and I can speak English.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ total period of 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~total period of 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Patients Reporting Suicidal Risks-Site 1
Number of Patients Reporting Suicidal Risks-Site 2
Number of Patients Screened for Suicidal Risks-Site 1
+1 moreSecondary study objectives
Follow-up Service Provision (Number)- Site 1
Follow-up Service Provision (Number)- Site 2
Parents Reporting Acute Care Usage (Number)- Site 1
+43 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Treatment As Usual (TAU)Active Control1 Intervention
Review all medical records for patients for the standard of care used at the facility for suicide assessment and risk. Determine if the enrolled patients were assessed and if risks are present.
Group II: NIMH Clinical PathwayActive Control1 Intervention
Implementation of an adapted/tailored version of the NIMH Clinical Pathway, which identifies a workflow and tools for routine suicide risk screening, assessment, safety planning and follow-up.
Find a Location
Closest Location:West Virginia University· Morgantown, WV· 164 miles
Who is running the clinical trial?
West Virginia UniversityLead Sponsor
190 Previous Clinical Trials
64,710 Total Patients Enrolled
1 Trials studying Suicide
850 Patients Enrolled for Suicide
Mary Christensen, PhD, LICSWPrincipal InvestigatorWest Virginia University